Cellectar Biosciences Inc (CLRB)
3.06
-0.05
(-1.61%)
USD |
NASDAQ |
Apr 24, 16:00
3.055
0.00 (0.00%)
After-Hours: 20:00
Cellectar Biosciences Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2009 | -66.53K% |
September 30, 2009 | -20.02K% |
June 30, 2009 | -15.03K% |
March 31, 2009 | -5.86K% |
December 31, 2008 | -5.87K% |
September 30, 2008 | -7.14K% |
June 30, 2008 | -10.24K% |
March 31, 2008 | -85.22K% |
December 31, 2007 |
Date | Value |
---|---|
September 30, 2007 | |
June 30, 2007 | |
March 31, 2007 | |
December 31, 2006 | |
September 30, 2006 | |
June 30, 2006 | |
March 31, 2006 | |
December 31, 2005 | |
September 30, 2005 | -7.59K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Eli Lilly and Co | 23.41% |
Actinium Pharmaceuticals Inc | -11.51K% |
Bristol-Myers Squibb Co | 15.35% |
Altimmune Inc | -85.52K% |